Miller DB - Search Results

1

The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity.

Miller DB, Ali SF, O'Callaghan JP, Laws SC. Miller DB, et al. Ann N Y Acad Sci. 1998 May;844(1):153-165. doi: 10.1111/j.1749-6632.1998.tb08230.x. Ann N Y Acad Sci. 1998. PMID: 29090819

2

Defining "neuroinflammation".

O'Callaghan JP, Sriram K, Miller DB. O'Callaghan JP, et al. Among authors: miller db. Ann N Y Acad Sci. 2008 Oct;1139:318-30. doi: 10.1196/annals.1432.032. Ann N Y Acad Sci. 2008. PMID: 18991877

3

The interactions of MK-801 with the amphetamine analogues D-methamphetamine (D-METH), 3,4-methylenedioxymethamphetamine (D-MDMA) or D-fenfluramine (D-FEN): neural damage and neural protection.

Miller DB, O'Callaghan JP. Miller DB, et al. Ann N Y Acad Sci. 1993 May 28;679:321-4. doi: 10.1111/j.1749-6632.1993.tb18315.x. Ann N Y Acad Sci. 1993. PMID: 8099774 No abstract available.

4

Neurotoxicity of d-amphetamine in the C57BL/6J and CD-1 mouse. Interactions with stress and the adrenal system.

Miller DB, O'Callaghan JP. Miller DB, et al. Ann N Y Acad Sci. 1996 Oct 31;801:148-67. doi: 10.1111/j.1749-6632.1996.tb17438.x. Ann N Y Acad Sci. 1996. PMID: 8959030

5

The impact of gender and estrogen on striatal dopaminergic neurotoxicity.

Miller DB, Ali SF, O'Callaghan JP, Laws SC. Miller DB, et al. Ann N Y Acad Sci. 1998 May 30;844:153-65. Ann N Y Acad Sci. 1998. PMID: 9668673

6

Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.

Miller DB, O'Callaghan JP, Ali SF. Miller DB, et al. Ann N Y Acad Sci. 2000 Sep;914:194-207. doi: 10.1111/j.1749-6632.2000.tb05196.x. Ann N Y Acad Sci. 2000. PMID: 11085321

7

Chronic treatment with supraphysiological levels of corticosterone enhances D-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse.

Johnson EA, O'Callaghan JP, Miller DB. Johnson EA, et al. Among authors: miller db. Brain Res. 2002 Apr 19;933(2):130-8. doi: 10.1016/s0006-8993(02)02310-7. Brain Res. 2002. PMID: 11931857

8

d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity.

Johnson EA, Shvedova AA, Kisin E, O'Callaghan JP, Kommineni C, Miller DB. Johnson EA, et al. Among authors: miller db. Brain Res. 2002 Apr 19;933(2):150-63. doi: 10.1016/s0006-8993(02)02313-2. Brain Res. 2002. PMID: 11931860

9

Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease.

Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O'Callaghan JP. Sriram K, et al. Among authors: miller db. FASEB J. 2002 Sep;16(11):1474-6. doi: 10.1096/fj.02-0216fje. Epub 2002 Jul 18. FASEB J. 2002. PMID: 12205053

10

Elevated environmental temperature and methamphetamine neurotoxicity.

Miller DB, O'Callaghan JP. Miller DB, et al. Environ Res. 2003 May;92(1):48-53. doi: 10.1016/s0013-9351(02)00051-8. Environ Res. 2003. PMID: 12706754

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

335 results

Search Page

Filters